I've just started using HRV again after seeing this thread. It does capture my crashes quite well, and even when I'm feeling better the LF and HF numbers are still off.
I'm not sure this is the best place for discussing experimental meds. In general, none of us can give medical advice anyway.
Wikipedia lists the following side-effects:
That's quite a list.
Was he assessed and rejected before the start of the new financial year? If so, perhaps he can reapply this year?
It would make sense to put everything in near the end of the year, so that when it's rejected, you can submit again within a few months because it'll be a new financial year.
So really, we should be expecting failure most of the time, with the assumption that researchers will try again until they get it right or come up with a better idea.
Yeah, normally you'd anticipate their objections and try to answer them in advance. It happens in the arts funding world, too. But usually if you get turned away, you ask for feedback, tweak, and resubmit. You don't give up.
Then again, the Arts Council's Project Grants scheme has about a 38%...
That's one way of looking at it, but consider the other: if charities don't submit, then who will get the tender? Would that work out better or worse for the charities and the people they represent in the long run?
As you say, VO2 at VT is reduced in all but one of the studies, but not always by very large amounts. Only half look significant (the ones you've bolded). That raises questions of reliability. A measure that only produces a clear result half the time is worrying.
Maybe they mean that the CI and SVI contribute to disability in ME, but don't track with the different severity types. So they make the disease severe, but they don't vary if the disease is more severe. If so, it's very poor wording on their choice.
This site uses cookies to help personalise content, tailor your experience and to keep you logged in if you register.
By continuing to use this site, you are consenting to our use of cookies.